This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gw Pharma Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Tamás Biró: Innovator in Cannabinoid Treatments
Introduction
Tamás Biró is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of cannabinoid research, particularly in the treatment of inflammatory skin diseases. His innovative approach combines the therapeutic potential of cannabinoids with dermatological applications.
Latest Patents
Tamás Biró holds a patent for the "Use of cannabinoids in the treatment of inflammatory skin diseases." This invention relates to the application of one or more cannabinoids, including cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), cannabigervarin (CBGV), and tetrahydrocannabivarin (THCV). The patent addresses various inflammatory skin diseases, which may be caused by microbial infection-induced dermatitis, solar dermatitis, atopic dermatitis, and allergic contact dermatitis. He has 1 patent to his name.
Career Highlights
Tamás Biró is associated with Gw Pharma Limited, a company known for its focus on cannabinoid-based therapies. His work has contributed to advancing the understanding and application of cannabinoids in medical treatments.
Collaborations
He has collaborated with notable colleagues, including Colin Stott and Vincenzo Di Marzo, to further research in this innovative field.
Conclusion
Tamás Biró's contributions to cannabinoid research highlight the potential of these compounds in treating inflammatory skin diseases. His work continues to pave the way for future innovations in medical treatments.